Precision Neuroscience’s Layer 7 Cortical Interface [Photo courtesy of Precision Neuroscience]Brain-computer interface (BCI) maker Precision Neuroscience announced today that it closed a Series C funding round worth $102 million.

Precision Neuroscience的第7层皮质界面[图片由Precision Neuroscience提供]脑机接口（BCI）制造商Precision Neuroscience今天宣布，它完成了一轮价值1.02亿美元的C系列融资。

General Equity Holdings led the financing round, which brings the company to $155 million in total capital raised. B Capital, Duquesne Family Office, the investment firm of Stanley F. Druckenmiller and Steadview Capital participated. The company says its round makes it one of the best-funded companies in the growing BCI industry..

通用股权控股（General Equity Holdings）主导了这轮融资，使该公司筹集的总资本达到1.55亿美元。B Capital、Duquesne家族理财办公室、Stanley F.Druckenmiller的投资公司和Steadview Capital参与了此次投资。该公司表示，这一轮投资使其成为不断增长的BCI行业中资金最雄厚的公司之一。。

An SEC filing earlier this fall said the company had brought in at least $93 million in the Series C round.

今年秋天早些时候，美国证券交易委员会提交的一份文件称，该公司在C轮交易中至少获得了9300万美元。

Precision Neuroscience plans to use the funds to expand its team, advance its clinical research efforts and refine future versions of its AI-powered brain implant. The company’s Layer 7 thin-film BCI features 1,024 electrodes embedded in a flexible film that conforms to the brain surface. The film comes in at one-fifth the thickness of a human hair..

精密神经科学计划利用这些资金扩大团队规模，推进临床研究工作，改进人工智能大脑植入物的未来版本。该公司的第7层薄膜BCI具有1024个电极，这些电极嵌入到与大脑表面一致的柔性薄膜中。这部电影的厚度只有人类头发的五分之一。。

This device aims to help users with severe paralysis operate digital devices, like computers and smartphones, using their thoughts.

该设备旨在帮助患有严重瘫痪的用户使用他们的想法操作数字设备，如计算机和智能手机。

“We’re beginning by addressing some of the most debilitating disorders—severe spinal cord injury, stroke, ALS—and our goal is to develop a product that is safe enough, and scalable enough, to treat a broad range of neurological conditions,” Michael Mager, co-founder and CEO, said. “This funding brings us one step closer to that vision.”.

联合创始人兼首席执行官迈克尔·马格（MichaelMager）说：“我们正在着手解决一些最令人衰弱的疾病，包括严重的脊髓损伤、中风、肌萎缩侧索硬化症，我们的目标是开发一种足够安全、可扩展的产品，用于治疗各种神经系统疾病。”。“这笔资金使我们更接近这一愿景。”。

The likes of Neuralink, Synchron and many more are also vying to bring technology like this to market. Many of these companies have featured on various MassDevice lists of BCI and neurotech companies you need to know in recent years:

Neuralink、Synchron等公司也在争相将此类技术推向市场。近年来，这些公司中的许多公司都在BCI和neurotech公司的各种MassDevice列表中占有一席之地：

2024 – Another 5 brain-computer interface companies you should know

2024年——你应该知道的另外5家脑机接口公司

2024 – 7 neurotech companies you need to know

2024-7家你需要了解的神经科技公司

2023 – 5 more brain-computer interface companies you need to know

2023-5家你需要了解的脑机接口公司

2022 – 7 brain-computer interface companies you need to know

2022-7家你需要了解的脑机接口公司